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Three modes for cryopreservation (CP) of human iPSC cells have been compared: STD: standard CP of small clumps with 10% of
CPAincryovials, ACC: dissociationofthe cells with Accutaseandfreezing in cryovials,andPLT: programmed freezing ofadherent
cells in plastic multiwell dishes in a programmable freezer using one- and multistep cooling protocols. Four CPAs were tesetd:
dimethyl sulfoxide (DMSO), ethylene glycol (EG), propylene glycol (PG), and glycerol (GLY). The cells in ACC and PLT were
frozen and recovered after thawing in the presence of a ROCK inhibitor Y-27632 (RI). EG was less toxic w/o CP cryopreservation
than DMSO and allowed much better maintenance of pluripotency after CP than PG or GLY. The cells were cryopreserved very
eﬃciently as adherent cultures (+RI) in plates (5-6-fold higher than STD) using EG and a 6-step freezing protocol. Recovery
under these conditions is comparable or even higher than ACC+RI. Conclusions. Maintenance of cell-substratum adherence is a
favorableenvironment that mitigates freezing and thawing stresses (ComfortFreeze
￿ concept developed by CELLTRONIX). CP of
cells directly in plates in ready-to-go after thawing formatfor HT/HC screening can be beneﬁcial in many SC-related scientiﬁc and
commercial applications such as drug discovery and toxicity tests.
1.Introduction
Human pluripotent stem cells (hPSCs) hold great potential
forcell therapy and regenerative medicine and as useful tools
to demonstrate in vitro embryotoxicity. Cryopreservation
(CP), storage, and shipment of hPSCs are key elements
for eventual clinical applications, which will require large
numbers of quality-controlled pluripotent stem cells. While
eﬀectiveCPprotocolsforordinary celllinesand evenmurine
embryonic stem cells (mESCs) are well established, this is
not the case for hPSCs due to low recovery rates of viable
and pluripotent cells following freezing, and the slow hESC
growth rate, so the time from thawing to obtaining cultures
suitable for experimentation can be weeks [1]. This problem
is not merely an inconvenience because extended culture
periods exert increased selective pressure on the cell popula-
tionenhancingthelikelihoodofphenotypicvariationand/or
alterations in potency. We demonstrated [1]t h a ts t a n d a r d
slow freezing of hESCs with 10% DMSO causes loss of Oct4
pluripotency marker expression so that only 5–10% of the
initial pluripotent cell pool remains Oct4+ after thawing
[1]. To date, several attempts to optimize CP of hESCs
have been made [2–16]. The eﬀects of freezing on induced
PSCs (iPSCs) are largely unexplored, except for some recent
publications[17,18].Therefore, developmentand validation
of eﬃcient protocols are required in order to establish
repositories for cryopreserved cells that can be thawed to
yield uniform cultures. Eﬃcient, robust, and user-friendly
CP technologies for primary hPSCs would substantially
shorten the time to restore cryobanked colonies, minimize
potential phenotypicdrift ofthecells, and improveshipment
safety after CP. Moreover, distribution of cells in 96-well
plates could simplify end-user screening applications such as
in vitro embryotoxicity. As such, CP remains a substantial
roadblock for PSC-related applications, whether for basic
research, transitional research for regenerative medicine, or
development of drug screening and embryotoxicity tests
where PSCs are to be used as the reporting cells [19].2 Stem Cells International
During CP, cells undergo many steps associated with
substantial stresses. The commonly used methods for CP
of single cells in suspension may damage cells at several
points in the process, including: (i) detachment from the
dish surface, (ii) dissociation into single cells/small clusters,
and(iii)centrifugationpriortoaliquotingintocryovials.The
cells must then be placed into a freezing medium, which
usually contains one or a cocktail of several cryoprotective
agents (CPAs) that can damage the cells osmotically and/or
introduce speciﬁc CPA-related chemical toxicity. During
cooling to suprazero temperatures, the cell membranes can
undergo lipid phase transition, which if suﬃciently rapid,
can induce cold shock injury. During freezing, the cells
can be compromised by intracellular ice if the cooling in
the range between 0◦Ca n d−70◦C occurs too fast or if
the freezing rate is too slow, since the cells shrink as the
liquid phase molality increases as the temperature drops.
This excessive shrinkage is eventually lethal as a result of
these solute eﬀects. During storage, cells can experience
thermalcyclingduetoliftingandreimmersioninthefreezing
cryocontainer when samples in the same container are
retrieved. Cells must be thawed under optimal conditions to
prevent osmotic shock, so ideally the thawing rate should
match that of freezing (although for many hPSCs faster
thawing rates are preferable). After thawing, the cryomedia
must be removed (eluted), which may introduce additional
CPA and in turn induce osmotic shock. Thawed cells are
usually then replated in culturing medium and may undergo
fast (e.g., necrotic) death after failure to attach, while re-
attached cells may become apoptotic.
Our goal has been to resolve the potential sources of
cytotoxic stress in a systemic way. In this paper, we report
ﬁrst stepsin thisdirection, namely,eﬃcientcryopreservation
of (1) dissociated, (2) adherent hPSC-derived iPSCs (3) with
ethylene glycol (EG), (4) the Rho-associated kinase (ROCK)
inhibitorY-27632, and (5) CPusing a programmable freezer.
2.GeneralMaterialsand Methods
2.1. Derivation of hESC-iPSCs
2.1.1. hESC and hiPSC Culture Conditions. Undiﬀerentiated
H9 hESCs cells and hIPSCs were cultured as described
in [20]. Brieﬂy, cells were cultured in Knockout Dul-
becco’s modiﬁed Eagle’s medium (KODMEM, Invitrogen,
no. 10829-018) supplemented with 1mM L-glutamine with
20% Knockout Serum Replacement medium (KOSR, Invit-
rogen), 1mM sodium pyruvate, 0.1mM nonessential amino
acids (NEAA, Invitrogen), 50U/mL penicillin, 50µg/mL
streptomycin (Invitrogen), 0.1mM beta-mercaptoethanol
(Invitrogen), and 8ng/mL basic ﬁbroblast growth factor
(bFGF, Sigma no. F0291-25UG). hESCs and hiPSCs were
grown on Matrigel (growth factor-reduced, BD Bioscience)
coated 6-well plates (Corning, Inc. no. 3506) on a feeder
layerofprimary MEFsfromE13.5CD-1mice.H9and hiPSC
lines were passaged following enzymatic digestion with
collagenase IV (Invitrogen, no. 17104-019) approximately
every 7 days. Cells were routinely tested for mycoplasma
(MycoAlert; Cambrex, Walkersville, MD).
2.1.2.GenerationofH9-Derived Fibroblasts. Undiﬀerentiated
H9 cells were subjected to a standard spontaneous diﬀer-
entiation protocol via EB formation, as described in [20].
Brieﬂy, collagenase IV-treated hESC colonies were dispersed
by mechanical pipette trituration into cell aggregates of 500
to 800cells. Aggregateswere rinsed twice with diﬀerentiation
medium (hESC medium without bFGF) before being re-
plated on low attachment plates (Corning, Inc. Costar no.
3171). The medium was exchanged on day 2 and on every
second day thereafter. After 6 days in suspension, EBs
were transferred onto 0.1% gelatin-coated tissue culture
dishes where they attached. Cells were maintained under
diﬀerentiation conditions for 1–3 months and composed
of heterogeneous cell populations. After 1–3 months cells
were dissociated with 0.25% Trypsin-EDTA (Invitrogen)
and plated onto gelatin-coated 10-cm dishes. After several
passages cells had predominantly ﬁbroblast phenotype and
were named hESC-derived ﬁbroblasts (hdFs).
2.1.3. Generation of Human iPS Cells. Passages 8–10 of
hdF were used for reprogramming. We applied standard
Yamanaka protocol [21] with minor modiﬁcations. Original
pMXs retroviral vectors encoding for hOct4, hSox2, hKlf4,
and hc-Myc were obtained from Addgene and pseudotyped
with VSV-G envelop protein (a gift from Gerald Pao, Salk
Institute). Semiconﬂuent hdFs were transduced overnight
with the supernatant containing all four viruses. Trans-
duction was repeated two more times with the fresh viral
supernatants. On day 6 after the ﬁrst infection cells were
dissociated and platedonirradiated MEFs. 5×104 ﬁbroblasts
were seeded onto 10cm dish. Next day medium was changed
tohuman EScellmedium containing 8ng/mL bFGF.Human
ES cell-like colonies appeared on day 12–14 after replating
on MEFs and were ready to be manually picked on day 17-
18. Reprogrammed colonies were expanded and cultured as
individual human iPS cell lines.
2.1.4. Immunochistochemistry. The cells were rinsed with
PBS, microphotographed in bright ﬁeld (BF) on a CKX 41
inverted microscope, and ﬁxed with 4% paraformaldehyde
(PFA) diluted in PBS for 10min at room temperature (RT).
After permeabilization and blocking with PBSAT (3% BSA
and 0.5% Triton X-100 diluted in PBS) for 1h at RT, the
cells were incubated overnight at 4◦Cw i t hp r i m a r ya n t i -
Nanog mouse monoclonal antibody (Ab) (Abcam, USA) at
a dilution of 1:200. On the following day, samples were
washed with PBS and incubated for 1hr at RT with an Alexa
555 conjugated secondary antibody (Invitrogen/Molecular
Probes, USA) and counterstained with Hoechst 33342
(1µg/mL; Sigma). The cells were photographed with red
and blue ﬁlters on an Olympus IX-71 inverted microscope.
Anti-Oct4 antibodies were not used since they would not
discriminate between endogenous and exogenous viral Oct4
expression.
3.ParticularM & Mand Results
3.1. Toxicity of Four Diﬀerent Cryoprotectants. We earlier
hypothesized that DMSOcanbe intrinsically toxicfor hPSCsStem Cells International 3
and should be substituted with a nontoxic CPA [1]. Ina pilot
study we found that ethylene glycol (1,2-ethane diol, EG)
provided equal protection in cryopreservation of 293 cells so
we considered this diol as a good candidate for substitution
of DMSO. We also tested propylene glycol (1,2-propane diol,
PG)andglycerol(GLY).Thecellswereexposedin10%(w/w)
of the CPAs for 30 min at 37◦C. Recovery of the Calcein-
PM+/7AAD-cell in comparison with control (QUANTA
allows precise measurement of the cell concentration that
was converted into total cell yield). The cells were then
detached and plated according to the routine procedure,
and on day 2, before the ﬁrst change of the medium, the
unattached cellswere also harvested. The averageattachment
eﬃciency of the untreated control was in a range 65–77%,
and practically 95% of the attached iPS cells were Nanog-
positive after 2 days of incubation.
To excludethe osmotic damage introduced by permeable
cryoprotectants, both addition and elution of the CPAs was
performed in a stepwise manner according to the Fixed
Shrinkage/Swelling(FSS)methoddevelopedbyuspreviously
[22]. Additionwas performed in 3 steps: ﬁrst, the old culture
medium was aspirated, and 500µL of new medium was
added.Itwas followedby additionof140,200,and260ofthe
stock medium containing 2x (20%) CPA then washed twice
with PBS and further incubated for 24hrs.
The ﬂoating clusters and single cells were then thor-
oughly collected by aspiration and marked as “Non-At-
tached,” centrifuged at 500g×10min, washed with PBS
twice, and Accutase was added to the cells for 5min at 37◦C
for complete cell dissociation. The intervals for equilibration
between steps were approx. 20sec.
Elution was performed in 5 steps: approximately 200µL
of the pellet was left and 200µL, 350µL, 650, and 800µLo f
PBS were added with intervals approx. 20sec. The liquid was
then aspirated, and new PBS was added.
The actual experimental results (refered to as “iPSC
Recovery”) normalized to the control value are depicted in
Figure 1. We found that the toxicity DMSO was substantially
higher than that of the 3 other cryoprotectants: 30-min
exposurein10%-DMSOcausedlossof30%ofinitiallyplated
pluripotent cells in comparison to 5% in control untreated
with the agent cells. Ethylene glycol was less toxic (76% of
viable Nanog+ cell were recovered), which was comparable
with PG. Glycerol was least toxic with recovery comparable
with control (P>. 1). Results.D M S Ow a st h em o s tt o x i c ,
glycerol was the least toxic, and EG and PG showed the
intermediate levels of toxicity.
The toxicity of 4 CPAs can be ranked as following:
DMSO > EG ∼ PG > GLY (Figure 1). DMSO has been
well known as a toxic agent for stem and progenitor cells,
and particularly for human embryonic stem cells. It is also
known as a powerful diﬀerentiation agent that may interact
with the chromatin structure. We also found that DMSO
is substantially more toxic to hESC than EG, PG, and
GLY and comparable to ethanol and acetaldehyde (paper
will be published elsewhere). In contrast, in general EG is
considered less toxic in cryobiological literature, especially
at high concentration used for vitriﬁcation and somewhat
similar to PG, even though the data are controversial. In the
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Figure 1: Toxicity of 4 cryoprotective agents. The cells were incu-
bated one hour at 37◦C in 10% solutions of four CPAs: dimethyl
sulfoxide (DMSO), ethylene glycol (EG), propylene glycol (PG),
and glycerol (GLY). Recovery of the Calcein-PM+/7AAD-cells in
comparison with control (QUANTA allows precise measurement
of the cell concentration that was converted into total cell yield).
The cells were then detached and plated according to the routine
procedure, and on day 2, before the ﬁrst change of the medium,
the unattached cells were also harvested. The average attachment
eﬃciencyoftheuntreated controlwasinarange65–77%,andprac-
tically 95% of the attached iPS cells were Nanogpositive after 2 days
of incubation (measured by using software imaging). The actual
experimental results (refered to as “iPSC Recovery”) normalized
to the control value are depicted in Figure 3 (group “TOX”). The
diﬀerentlettersindicatestatisticallysigniﬁcantdiﬀerence amongthe
two CPAs. M ±m, n = 3.
majority type of cells, glycerol is considered the least toxic,
and it is the least permeable. In general, a permeable CPA
with smaller molecular weight such as DMSO, methanol or
ethanol is the most permeable and more toxic than CPAs
with higher MW such as glycerol. We have found similar
eﬀects for 2-cell mouse embryos, and for hESCs, as well as
in this study. However, application of the standard freezing
protocol (cells frozen in clusters in cryovials) using the same
as 10% DMSO revealed that in all cases the cell recovery rate
was as follows: DMSO ∼ EG   PG > GLY. (Figures 2 and 3,
group “STD”, see Results below).
3.2. Cryopreservation of Dissociated iPS Cells. As described
above, cell detachment from surfaces containing ECM
molecules can cause massive cell death and diﬀerentiation.
However, from a cryobiological perspective, CP of single
cell suspensions is preferable to clusters. We address this
issue by adding a Rho-kinase (ROCK) inhibitor Y-27632
(RI in the text) that helps cells withstand detachment and
dissociation [32]. Addition of RI to the cell clusters also4 Stem Cells International
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Figure 2: Recovery of viable iPSCs after diﬀerent protocols of
cryopreservation. Freezing of iPSC 3 was performed using 3 basic
protocols: STD: standard routine slow uncontrolled freezing of
smallclumpswith10%ofCPAinNunc cryovials,ACC:dissociation
of the cells with Accutase and freezing in cryovials and freezing and
re-plating in the presence of a ROCK Inhibitor Y-27632 (RI), PLT:
Freezing of adherent cells in 4-well plates in EG. Four CPAs were
used in STD and ACC experiments, which are abbreviated above.
The cells in ACC and PLT were frozen and recovered after thawing
i nt h ep r e s e n c eo fR I .T h en u m b e r so nt h el a s tg r o u pi n d i c a t e s
programmed freezing protocols described in Section 3.3 and in
Figure 4. Fluorescent microphotographs of some of experimental
variations are shown on Figures 3 and 4. M ± m, n = 3.
improved recovery rates but at lesser extent and was not
as beneﬁciary in the matter of total viable yield and cell
growth after thawing as for fully dissociated cells (see also
our companion paper).
More striking results were obtained when detached iPSCs
were dissociated into singlets using the enzyme cocktail
Accutase (Figures 2 and 3, group “ACC”). In this case,
although the freezing curve was not optimized (standard
cooling in a Nalgene alcohol bath of −80◦Cw a su s e d ) ,t h e
recovery signiﬁcantly diﬀered from the group “STD.” Note
that the absence of RI dropped the recovery dramatically. At
the same time the maximum peak (EG +RI) was higher than
for the STD group frozen as cell clusters.
3.3. Cryopreservation Attached Cells in Plates. Since the stan-
dardfreezing protocolrequiresdetachment,wehypothesized
that the recovery could be improved if cells were not
disturbed from their “natural” environments. We thus froze
cells in 4-well plates (Figure 2,g r o u p“ P L T , ”Figure 4). We
explored several freezing protocols: (1) transferring cells
into a −80◦C freezer in a “Mr. Frosty” isopropanl cooler
(Nalgene)for24hrsfollowedbyplungingintoliquidN2 with
an initial cooling rate of ∼− 1◦C/min; three programmed
freezing protocol in a programmable freezer, namely; (2)
one-step cooling from 0◦C (CPA was added on ice) to
−140◦Ca t−1◦C/min; (3) three- step protocol that imitates
a Nalgene cryovials left at −80◦Ci n“ M r .F r o s t y ”( [ 23],
Figure 6): (i) −0.63 ◦C/min from 0◦C (CPA was added on
ice) to −5◦C; (ii) −0.20◦C/min to −10◦C; (iii) −0.48◦C/min
to −80◦C, than transfer to LN2; (4) six-step programmed
protocol developed by us: (i) −1◦C/min from 0◦C( C P Aw a s
added on ice) to −10◦C; (ii) hold for 30 min at −10◦C; (iii)
−3◦C/min to −40◦C, than transfer to LN2;( i v )−1◦C/min to
−60◦C; (v) −0.33◦C/min to −80◦C; (vi) hold at −80◦Cf o r
5min,thantransfertoLN 2.
The six-step protocol yielded the best results with 63%
recovery in comparison to 10–12% for “standard” freezing.
Notethatwhenweappliedthesix-stepapproachtoAccutase-
dissociated cells frozen in cryovials (group “ACC”) with
component X no improvement was seen apparently due
to the diﬀerent geometry of detached sphere-like cells and
ﬂattenedattachedcells. Thisissue needsfurtherinvestigation
as suspended cells may require a diﬀerent freezing protocol.
We are now looking to test another chemical, E, that would
minimize cell damage after thawing.
This example illustrates our approach that allowed us to
obtain a sixfold increase in cell recovery (10 versus 63%)
in the space of two months. Method of freezing in plates
is robust and requires minimal labor. However, the best
achievement required a programmable freezer, which is not
expensive in comparison with the cost of additional labor
and chemical required for cells frozen in one uncontrollable
step (Figure 2).
4.Discussion
While many aspects of these developments were used
in previously documented protocols [2–16]; however, the
reported results diﬀer widely among labs and cell lines. Our
clear distinction and innovation was to use the cumulated
data in concert as a whole. Another problem is that a wide
variety of the methods of assessment of recovery used in
the abovementioned publications makes direct quantitative
comparisonofdiﬀerentresultsverydiﬃcultifnotsometimes
impossible. We have decided not to use any colony assay due
to large variability of the size and amount of the colonies
that can be plated into a particular well, thus, making
the “number of colonies” as an unreliable parameter for
quantiﬁcation. We instead, used the number (% to the total
amountofharvestedcells)ofGFP-positivecellsthatexcluded
a negative viability marker 7AAD as the characteristic of the
attached cells. We also precisely (using QUANTA Coulter
counter option) measured the amount of nonattached and
attached cellsbecause itwas also impossible toplatethesame
amount of cells per a well even if the cells were dissociated
prior to freezing and plating, and especially if they were
frozen in clumps. Thus, combination of the assessment of
% the cells that reattached to the surface of the well versus
ﬂoating non-attached cells and the percentage of Oct4-
positive viable (7AAD-) reattached cells would give us a
fair assessment of the overall recovery, that is, the yield of
viable pluripotent SCs after CP (VY). If that parameter is
normalized to the yield of nonfrozen cells that are split
according to the standard protocol (in clumps), that wouldStem Cells International 5
DMSO EG PG GLY
STD
ACC
Figure 3: Cryopreservation of human iPSCs in vials. Fluorescent microscopy of human induced pluripotent stem cells. Color combined,
Nanog(immunestaining),andHoechst.The intensityofhPGK-H2B-eGFP wasweak (notshown)but quantiﬁable by Cell LabQUANTATM.
The photoswere takenonday 6 after thawing.RowSTD: standardfreezing with10%of fourdiﬀerent cryoprotective agents(CPAs)indicated
in columns: dimethyl sulfoxide (DMSO) (current routine), ethylene glycol (EG), propylene glycol (PG), and glycerol (GLY). Row ACC:
cryopreservation of human iPSCs after dissociation into single cells with Accutase and in the presence of ROCK inhibitor Y-27632 and
diﬀerent CPAs. Note: cryopreservation of dissociated by Accutase cells w/o RI resulted in 90% of cell death (Figure 2).
−80◦C (uncontrolled) 3St 6St
Nanog
(a)
(b)
Nanog+Hoecsht
−1◦C/min
Figure 4: Cryopreservation of aderent human iPSCs in plates. Fluorescent microscopy of human induced pluripotent stem cells frozen in
adherent statein 4-well plates.First row:Nanog(immunestaining),secondrow: combinedNanog + Hoechst. The photos were takenon day
3 after thawing. In all cases, ethylene glycol (EG) and ROCK inhibitor Y-27632 were used.−80◦C: uncontrolled freezing in a –80◦C freezer
in a Styrofoam box (∼− 1◦C/min at the ﬁrst stage of freezing). The yields of viable, and especially Nanog-positive cells, are very low (see
Figure 3). −1◦C/min: one-step freezing in a programmable freezer (Custom Biogenics, Inc, series 2100); Note 1: eroded edges of the colony
and diﬀerentiation of the adjacent cells within the colony. 3St: three-step freezing protocol (described in Section 3.3)i nap r o g r a m m a b l e
freezer. 6St: six-step freezing protocol (described in Section 3.3) in a programmable freezer. Note 2: clear distinct edges of the colonies in
BOTHcases anddiﬀerentiated (Nanog-negative) cells (blue) outside the colony in the 3-Step protocol. QUANTA has conﬁrmed substantially
higher attachment eﬃciency and a larger 7AAD−/GFP+ pool of viable iPSCs in cases of multistep controlled freezing (Figure 3).6 Stem Cells International
constitute the assessment of cryosurvival (SR,w h i c ha l s o
includes survival to CP-related protocols such as addition
and removal of the CPAs and centrifugation). Those two
parameters (VY and SR) would give an objective assessment
of a particular CP protocol as the whole.
We previously hypothesized that DMSO, as a potent
diﬀerentiating agent, can be intrinsically toxic for hPSCs
and should be substituted with a non-toxic CPA [1]. And
indeed, DMSO has been found to be toxic to ESCs even in
miniscule concentrations if applied for long time ([19, 24],
our unpublished data). In a pilot study, we found that EG
provided equal to DMSO protection in cryopreservation
of 293 cells [25]. We have also reported that EG was less
t o x i ct o2 - c e l lm o u s ee m b r y o s[ 26]w h i l ei tm a n i f e s t e d
similar permeability characteristics (see [27] for references).
It made EG as an attractive alternative to DMSO so we ﬁrst
checked the potential toxicity by exposing iPSCs to 10% v/v
concentrations of DMSO, EG, and two other widely used
in cryopreservation CAPs propylene glycol and glycerol. We
found that the toxicity DMSO was substantially higher than
thatofthe3 othercryoprotectants: 30-minexposure in10%-
DMScausedlossof30%ofinitiallyplatedpluripotentcellsin
comparison to 5% in control untreated with the agent cells.
Ethylene glycol was less toxic (76% of viable Nanog+ cell
were recovered), which was comparable with PG. Glycerol
was the least toxic with recovery comparable with control
(P>. 1) so the relative toxicity could be expressed as
DMSO >> EG ∼ PG > GLY (Figure 1). DMSO has been well
knownasa powerful inducerofdiﬀerentiationand apoptosis
[28–30].
We also found that DMSO is substantially more toxic
to hESC than EG, PG, and GLY and comparable to ethanol
and acetaldehyde (a paper will be published elsewhere).
In contrast, in general EG is considered less toxic in
cryobiological literature, especially at high concentration
used for vitriﬁcation and somewhat similar to PG, even
though the data are controversial. In the majority type of
cells, glycerol is considered the least toxic while at the same
time, it is the least permeable. In general, a permeable CPA
with smaller molecular weight such as DMSO, methanol, or
ethanol is the most permeable and more most toxic than
CPAs with higher MW such as glycerol. We have found
similar eﬀects for 2-cell mouse embryos, and for hESCs, as
well as in this study. However, application of the standard
freezing protocol (cells frozen in clusters in cryovials) using
the same 10% v/v concentration (though slightly diﬀerent
osmolality) revealedthat thecell recovery rate wasas follows:
EG ∼ DMSO > PG >> GLY.(Figures2and3,gr oup“ STD”).
Cryopreservationofdissociated hPSCshasrecentlydrawn
attention after publications on the use of Accutase as a
less harmful detaching and dissociating agent [31]a n d
especially after Watanabe et al. reported the protective role
of a Roh-associated kinas (ROCK) inhibitor Y-23672 after
hES cell detachment and dissociation [32]. In all recently
available reports [8, 10, 17, 18, 33–35] the authors found
beneﬁcial role of cryopreservation of hES and iPS cells after
dissociation and application of Y-23672 even though direct
comparison of the eﬃciency is not possible mostly due to
diﬀerent methods of estimation of viability and recovery of
pluripotent cells and PS cell colonies. The mechanism of the
protective role of RI can be as inhibitor of apoptosis that
was caused by the activation of the ROCK pathways during
dissociation and detachment, pointed out in the original
Watanabe’s work; at the same time, freezing (and cooling)
per se can cause speciﬁc cold and osmotic related damages
such as rearrangement of F-actin, activation of p53,and ROS
production [36]. Overall, as we can see in Figure 1,C Po f
dissociated cells had clear advantage over the standard CP
in clumps, especially if EG was used (51% versus 8% resp.,
P<. 001), in a range reported by other investigators as well
asingoodconcordancewithourdataonOct4/eGFP-infected
human ESCs (results will be published elsewhere). We did
not explore addition of Y-23672 one hr prior freezing for CP
o fi P S C sa so t h e r sd i d[ 10, 35] but we found it somewhat
more beneﬁcial for CP of Oct4/eGFP-infected human ESCs
in comparison to addition of Y-23672 after freezing only.
Cryopreservation ofadherent stemcells in monolayersin
plates is a relatively novel method. Beside some anecdotic
reports on freezing mouse ESC plates, and recent work by
Nagy and colleagues [37, 38]a n dM i y a m a t oe ta l .[ 39],
very few reports are published on CP of adherent human
pluripotent SCs [7, 40]. We believe that CP in adherent
state is not only convenient for several applications such as
high cell-based throughput and high-content screening but
it also causes less damage so we (CELLTRONIX) developed
in 2006–2008 a “universal” technological approach that we
call ComfortFreeze
￿, that can be applied not only to the
pluripotent stem cells but hESC/iPSC-derived neural and
cardiac progeny as well (results to be published elsewhere).
Eﬃcient, robust, and customer-friendly CP technologies
for primary hPSCs would substantially shorten the time
to restore cryobanked colonies, improve shipment safety,
eliminate possible biased selective pressure within a PSC-
line after CP and distribution of cells frozen in 96-well plates
that could be used immediately for embryotoxicity and drug
screening in PSC-based toxicology in vitro kits.
5.Conclusions
Both dissociation of iPSCs with Accutase in the presence of
a ROCK inhibitor and ethylene glycol AND programmable
freezing in adherent stage (ComfortFreeze
￿) havedrastically
improved (up to 6-fold) the yield of pluripotent cryopre-
served stem cells in comparison to the standard freezing
in clumps without ROCK inhibitor. Cryopreservation of
adherent cells in plates has also showed a higher eﬃcacy and
lower time for restoration of the colonies to the unfrozen
level than dissociation with Accutase.
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